Senior Associate I Manufacturing, Cell Therapy at Bristol-Myers Squibb

Leiden, South Holland, Netherlands

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Enthusiastic and passionate about cell therapy manufacturing
General understanding of Good Manufacturing Practices (GMPs)
Innovative and intellectually curious
Goal-oriented and flexible
Ability to work effectively and efficiently on a team
Demonstrates safety, quality, and GMP compliance at all times
Strong practical and theoretical knowledge in their work
Proficient in process systems and supporting business systems

Responsibilities

Execute operations described in Standard Operating Procedures (SOPs) and batch records
Complete documentation required by governing controlled documents and batch records
Serve as SME on manufacturing unit operations and business processes
Solve complex problems; take new perspectives using existing solutions
Perform tasks in a manner consistent with established safety policies, SOPs, quality systems, and GMP requirements
Complete training assignments to ensure the necessary technical skills and knowledge
Train others on processes, SOPs, Work Instructions to successfully complete manufacturing operations
Mentor to junior/medior associates
Write no impact / minor deviations and support investigations, as required
Work to identify innovative, continuous improvement solutions
Collaborate with support groups on recommendations and solving technical and operational problems
Provide assistance setting up manufacturing areas and equipment/fixtures, as needed
Write manufacturing operating procedures

Skills

Cell Therapy Manufacturing

Commercial Manufacturing

GMP

Biopharmaceutical Production

Aseptic Processing

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free